Literature DB >> 6192029

Inhibition of intraduodenal trypsin does not stimulate exocrine pancreatic secretion in man.

J Dlugosz, U R Fölsch, W Creutzfeldt.   

Abstract

Inhibition of intraduodenal trypsin stimulates pancreatic secretion in rats and swine. This finding is controversial in healthy humans. The present study was designed to find whether a 'negative-feedback' mechanism exists in man. A 7-lumen tube equipped with two balloons was passed into the duodenum in 18 healthy volunteers. During a constant intravenous infusion of secretin (0.1 CU/kg/h) the duodenum was perfused with 0.9% NaCl solution (20 ml/10 min). Polyethylene glycol (10 g/l) served as nonabsorbable marker. Aprotinin (0.5 X 10(6) KIU/10 min or 1 X 10(6) KIU/10 min) was perfused intraduodenally during periods of constant pancreatic enzyme secretion for 30 min. During perfusion of the trypsin inhibitor aprotinin an almost complete inhibition of trypsin could be observed. However, at the same time or following the perfusion of aprotinin a significant augmentation of amylase, lipase or volume secretion did not occur. Thus, in the present study a negative-feedback control of pancreatic exocrine secretion by the intraduodenal trypsin concentration in man could not be demonstrated.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6192029     DOI: 10.1159/000198890

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  11 in total

Review 1.  Is there a duodenum-pancreas negative feedback? Views: pro and con.

Authors:  D F Magee
Journal:  Int J Pancreatol       Date:  1991-05

2.  Effect of loxiglumide (CR-1505) on bombesin- and meal-stimulated plasma cholecystokinin in man.

Authors:  J B Jansen; M C Jebbink; B R Douglas; C B Lamers
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 3.  Management of pain in chronic pancreatitis with emphasis on exogenous pancreatic enzymes.

Authors:  Paul M Hobbs; William G Johnson; David Y Graham
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-08-06

4.  Plasma CCK levels in patients with pancreatic insufficiency.

Authors:  T Bozkurt; G Adler; I Koop; H Koop; W Türmer; R Arnold
Journal:  Dig Dis Sci       Date:  1988-03       Impact factor: 3.199

Review 5.  On the role of cholecystokinin in pancreatic cancer.

Authors:  M K Herrington; T E Adrian
Journal:  Int J Pancreatol       Date:  1995-04

6.  Chronic diversion of bile to the urinary bladder induces pancreatic growth in dogs.

Authors:  M Takahashi; I Sasaki; H Naito; Y Funayama; C Shibata; N Ohtani; S Matsuno
Journal:  J Gastrointest Surg       Date:  2000 Sep-Oct       Impact factor: 3.452

7.  Influence of high-dose pancreatic enzyme treatment on pancreatic function in healthy volunteers.

Authors:  H Friess; J Kleeff; P Malfertheiner; M W Müller; K Homuth; M W Büchler
Journal:  Int J Pancreatol       Date:  1998-04

8.  Gastrin-releasing peptide and CCK after intraduodenal inhibition of proteases in dogs.

Authors:  R Nustede; W E Schmidt; M Jäger; F Stöckmann; H Köhler; U R Fölsch; H J Peiper
Journal:  Int J Pancreatol       Date:  1994-06

9.  Changes in plasma and duodenal cholecystokinin concentrations after pancreatic duct occlusion in rats.

Authors:  K Miyasaka; A Funakoshi; A Jimi; R Nakamura; M Matsumoto; K Kitani
Journal:  Dig Dis Sci       Date:  1992-03       Impact factor: 3.199

10.  Influence of treatment with pancreatic extracts on pancreatic enzyme secretion.

Authors:  J Mössner; H P Wresky; W Kestel; J Zeeh; U Regner; W Fischbach
Journal:  Gut       Date:  1989-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.